Skip to main content
. Author manuscript; available in PMC: 2017 Jun 13.
Published in final edited form as: Pharmacogenomics J. 2016 Dec 13;18(1):127–135. doi: 10.1038/tpj.2016.90

Table 2.

Summary of significant sulfonylurea-SNP interaction associations with QT, JT, and QRS intervals from ancestry-specific GWAS meta-analyses (P < 5 x 10−8)

Lead SNP Chr:position (hg19) Nearest gene Race Studies Min/alt alleles MAF Effect SE P Function Other GWAS Coding eQTL (P<5x10−8)
QT interval
 rs9966832 18:23405188 SS18 EA 3 G/A 0.03 −10.4 1.9 2.3E-08 Intergenic Periodontitis66
 rs830233 5:165403746 AA 4 A/G 0.05 −16.3 2.3 2.5E-12 Intergenic
JT interval
 rs1890262 1:62114402 TM2D1,NFIA EA 2 A/G 0.03 14.9 2.6 1.8E-08 Intergenic
 rs12468579 2:191832264 GLS,STAT1 AA 6 G/A 0.49 4.1 0.8 4.5E-08 Intergenic GLS6063, MFSD660
 rs1478173 3:162276405 AA 2 C/A 0.03 −15.0 2.1 1.0E-12 Intergenic
 rs17281245 4:182635289 TENM3 AA 5 C/T 0.06 8.8 1.5 5.4E-09 Intergenic
 rs7713675 5:28750307 LSP1P3 AA 4 C/T 0.05 −12.2 2.1 9.8E-09 Intergenic
QRS interval
 rs7595140 2:71551621 ZNF638,PAIP2B EA 4 G/C 0.03 −5.7 1.0 3.8E-08 Intergenic

EA = European ancestry, AA = African American, HA = Hispanic/Latino ancestry, MAF = minor allele frequency, SE = standard error. Studies = number of cohorts contributing to ancestry-specific analysis. Other GWAS = phenotypes associated with lead SNP (P < 5 x 10−8) in other genome-wide association studies. Coding = lead SNP in linkage disequilibrium (r2 > 0.8) with a protein coding variant. eQTL = transcripts associated with SNPs in linkage disequilibrium (r2 > 0.8) with lead SNP.